我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
12
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
6
50.0%
尚未招募
1
8.3%
招募中
5
41.7%
暂无批准数据
- BGI Group marked its 27th anniversary with a Shenzhen launch event presenting technologies spanning brain science, multi-omics diagnostics, active health management, nutrition, skincare, pet health and soil ecology. - BGI Genomics introduced a Digital Life Twin framework that cross-references routine annual checkup metrics with population-level data from large healthy cohorts to build individual baseline profiles. - The company unveiled a multimodal brain-on-chip system integrating on-chip neuronal and brain organoid culture with electrophysiological and optical interaction for neurological disease modeling and neuropharmacological screening. - BGI also presented the upgraded i99 Smart Health platform, the two-square-meter i3 Smart Cabin terminal, and expanded WGLIFE and BIOAGE molecular aging testing portfolios.